TXG
HOLD / NEUTRALNeutralComposite
58.70
Technical
97.80
Fundamental
32.70
Rank
—
Price
74.39
Hurst
0.59
As of
Sep 16, 2026
Daily
10x Genomics, Inc.
HealthcareMedical Devices10x Genomics develops and markets hardware, reagents, and analytical software for biological research across multiple global markets. The company operates several product platforms including Chromium for single-cell analysis, Visium for spatial transcriptomics, and Xenium for in situ RNA detection, along with complementary consumables and computational tools for data processing and visualization. Its customers include academic institutions, government agencies, and organizations in the pharmaceutical and biotechnology sectors.
Market cap
$9.1B
P/E (trailing)
—
P/E (forward)
914.44
PEG ratio
—
Dividend yield
0.00%
Beta
1.99
52w range
12.80 – 102.81
Return on equity
-9.40%
Profit margin
-12.18%
Revenue growth
-12.70%
Earnings growth
—
Price history
1Y: 70.11 (+414.0%) · range 13.00–97.74
Cycle position
51/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 23 · NOT READY · exit proximity 35
Conviction
27/ 100 · maturity 57%
VScore.2824
Buildup.2432
EMA entry setup.3023
Fundamentals.1833
Volume profile
POC
45.86
Price vs POC
+52.9%
Overhead supply
30%
Runway
+3.1%
Value area 20.27–71.44 · 30% of 120d volume overhead · moderate overhead
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 0.533 | Oct 29, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -23.48% | +4.53% | 15/20d |
| 40d | -23.48% | +4.53% | 15/40d |